- Stocks
- Healthcare
- NASDAQ: ZYXI

Price (delayed)

$9.38

Market cap

$298.05M

P/E Ratio

42.64

Dividend/share

N/A

EPS

$0.22

Enterprise value

$340.22M

Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery

Zynex's revenue has increased by 11% YoY and by 2.4% from the previous quarter

The gross profit has grown by 11% YoY and by 3% from the previous quarter

ZYXI's quick ratio is down by 30% QoQ but it is up by 15% YoY

Zynex's net income has plunged by 53% YoY and by 16% from the previous quarter

The EPS has plunged by 51% YoY and by 19% from the previous quarter

What are the main financial stats of ZYXI

Market
Valuations
Earnings

Shares outstanding

31.78M

Market cap

$298.05M

Enterprise value

$340.22M

Price to earnings (P/E)

42.64

Price to book (P/B)

9.12

Price to sales (P/S)

1.61

EV/EBIT

27.19

EV/EBITDA

18.93

EV/Sales

1.8

Revenue

$188.68M

EBIT

$12.51M

EBITDA

$17.98M

Free cash flow

$16.76M

Per share
Balance sheet
Liquidity

EPS

$0.22

Free cash flow per share

$0.52

Book value per share

$1.03

Revenue per share

$5.83

TBVPS

$3.03

Total assets

$126.23M

Total liabilities

$93.13M

Debt

$75.43M

Equity

$33.1M

Working capital

$56.23M

Debt to equity

2.28

Current ratio

3.58

Quick ratio

2.7

Net debt/EBITDA

2.35

Margins
Efficiency
Dividend

EBITDA margin

9.5%

Gross margin

79.7%

Net margin

4.3%

Operating margin

5.8%

Return on assets

5.8%

Return on equity

16.3%

Return on invested capital

10.1%

Return on capital employed

12%

Return on sales

6.6%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Zynex stock price performed over time

Intraday

-0.64%

1 week

7.08%

1 month

4.34%

1 year

0.75%

YTD

-13.87%

QTD

0.64%

How have Zynex's revenue and profit performed over time

Revenue

$188.68M

Gross profit

$150.29M

Operating income

$11.02M

Net income

$8.17M

Gross margin

79.7%

Net margin

4.3%

The net margin has plunged by 58% YoY and by 19% from the previous quarter

Zynex's operating margin has shrunk by 54% YoY

Zynex's net income has plunged by 53% YoY and by 16% from the previous quarter

The company's operating income fell by 48% YoY but it rose by 2.2% QoQ

What is Zynex's growth rate over time

What is Zynex stock price valuation

P/E

42.64

P/B

9.12

P/S

1.61

EV/EBIT

27.19

EV/EBITDA

18.93

EV/Sales

1.8

The EPS has plunged by 51% YoY and by 19% from the previous quarter

The P/E is 25% above the last 4 quarters average of 34.2 and 3.1% above the 5-year quarterly average of 41.6

The equity has declined by 49% year-on-year and by 28% since the previous quarter

The P/B is 21% more than the last 4 quarters average of 7.6 but 6% less than the 5-year quarterly average of 9.8

The price to sales (P/S) is 64% lower than the 5-year quarterly average of 4.5 and 15% lower than the last 4 quarters average of 1.9

Zynex's revenue has increased by 11% YoY and by 2.4% from the previous quarter

How efficient is Zynex business performance

The ROIC has plunged by 68% YoY and by 18% from the previous quarter

ZYXI's ROA has dropped by 61% year-on-year and by 18% since the previous quarter

The ROS has contracted by 50% YoY and by 11% from the previous quarter

ZYXI's ROE is down by 37% year-on-year and by 3% since the previous quarter

What is ZYXI's dividend history

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

Recent dividends

How did Zynex financials performed over time

The total assets is 36% more than the total liabilities

Zynex's total liabilities has surged by 100% YoY and by 2.6% QoQ

ZYXI's quick ratio is down by 30% QoQ but it is up by 15% YoY

The debt is 128% more than the equity

The equity has declined by 49% year-on-year and by 28% since the previous quarter

Zynex's debt to equity has increased by 38% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.